Clinical Trials Directory

Trials / Completed

CompletedNCT00108524

A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
146 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

This study compares two types of diet interventions: a low carbohydrate ketogenic diet (Atkins) and a low-fat diet combined with a medication (Orlistat).

Detailed description

Overweight and obesity are increasingly prevalent in the veteran population as well as the general public. For patients with obesity-associated illnesses, there are few effective treatment options available after failed attempts at diet and exercise, even though weight loss has been shown to alleviate these conditions. The purpose of this study is to compare the tolerability, safety, and efficacy of a low-carbohydrate ketogenic diet (Atkins) with a combination of a low-fat diet and Orlistat. The outcomes examined over a 48 week duration will include body weight, risk factors for heart disease (e.g., lipid profiles), and blood sugar. This is a randomized, parallel-intervention trial. Subjects (n=150) will be recruited from the Durham VAMC Ambulatory Care Clinics. All patients receive one of the two intensive weight loss interventions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLow carbohydrate ketogenic dietA low-carb diet limits carbohydrates - such as grains, starchy vegetables and fruit - and emphasizes dietary protein and fat.
DRUGOrlistatIn addition to the low fat diet, Orlistat is taken 3 times daily.
BEHAVIORALLow-fat dietParticipants receive counseling on a low fat diet over 48 weeks aimed at reducing fat and calorie intake

Timeline

Start date
2004-07-01
Primary completion
2007-12-01
Completion
2007-12-01
First posted
2005-04-18
Last updated
2014-04-17
Results posted
2013-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00108524. Inclusion in this directory is not an endorsement.